Login to Your Account



FDA Roundup

FDA Wants Risk Plan for Telavancin Use in cSSSI

By Catherine Hollingsworth


Monday, March 2, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription